11 Analysts Have This to Say About CVS Health
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) has received 11 analyst ratings in the last quarter, with 3 being bullish and 8 somewhat bullish. The average price target is $93.55, which is higher than the current price of $65.505. This average represents an 8.46% decrease from the previous average price target of $102.20.
September 01, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CVS Health has received positive analyst ratings, which could potentially increase investor confidence and drive the stock price up.
Analyst ratings often influence investor sentiment. In this case, the majority of the ratings are bullish, which indicates a positive outlook for the stock. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100